Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia 3Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Kidney Neoplasms 1Hodgkin Disease 1Graft vs Host Disease 1Congenital Abnormalities 1Carcinoma, Renal Cell 1Blast Crisis 1Anemia, Aplastic 1

Interventions

Paclitaxel 6Carboplatin 6Radiotherapy 5Erlotinib Hydrochloride 4pembrolizumab 3aldesleukin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Cyclophosphamide 2Bevacizumab 2veliparib 1trametinib 1spartalizumab 1satraplatin 1osimertinib 1onartuzumab 1nintedanib 1methyl-4-fluoro-4-deoxyglucose 1fludarabine phosphate 1fludarabine 1bemarituzumab 1anlotinib 1aflutinib 1Taxes 1Sorafenib 1Sirolimus 1Radiotherapy, Conformal 1Radiosurgery 1Pentostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Adenocarcinoma of Lung × Pentostatin × Clear all
NCT01362790 2019-06-06

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
55 enrolled 22 charts
GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡